A randomised, double blind, placebo controlled trial with vitamin D <sub>3</sub> as an add on treatment to interferon β-1b in patients with multiple sclerosis
Merja Soilu‐Hänninen(University of Turku), Massimo Filippi(Vita-Salute San Raffaele University), Julia Åivo(University of Turku), Irma Keskinarkaus(Oulu University Hospital), Lauri Herrala(Northern Ostrobothnia Hospital District), Johanna Krüger(Oulu University Hospital), Sari Atula(University of Helsinki), Irina Elovaara(Tampere University), Pentti J. Tienari(University of Helsinki), Marja‐Liisa Sumelahti(Tampere University), Taneli Sarasoja(Central Finland Health Care District), Maria A. Rocca(Vita-Salute San Raffaele University), Timo Kallio(Turku City Hospital), Britt-Marie Lindström
Cited by 268
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k